InBioGen Co

InBioGen Co R&D / Revenue

The R&D to Revenue Ratio of InBioGen Co (101140.KS) as of Oct 24, 2026 is 0.31 %. In the previous year, R&D to Revenue Ratio was 0.13 % — a change of 136.89% (higher).

R&D / Revenue

0.31 %

YoY

136.89%

Last updated:

R&D to Revenue Ratio of InBioGen Co is 2024 0.31 % . R&D to Revenue Ratio of InBioGen Co was 2023 0.13 % . It decreases by 136.89% higher compared to the previous year.

The InBioGen Co R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2014
0.17 KRW
Jan 1, 2021
0.23 KRW
Jan 1, 2022
0.03 KRW
Jan 1, 2023
0.13 KRW
Jan 1, 2024
0.31 KRW
The InBioGen Co R&D / Revenue history
YEARR&D / RevenueYoY
0.31 %+136.89%
0.13 %+308.06%
0.03 %-86.30%
0.23 %+34.40%
0.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InBioGen Co Stock analysis

What does InBioGen Co do? INBIOGEN CO., Ltd. generates revenue through four distinct business segments, leveraging its manufacturing and sales capabilities across diverse markets. The Kiosk Business segment operates unmanned payment machines within restaurants, karaoke rooms, and personal computer rooms, providing automated transaction solutions for these specific venues. This segment capitalizes on the demand for efficient, contactless payment infrastructure in high-traffic entertainment and dining areas. The Footwear Business segment focuses on the sale of children's shoes and adult shoes, serving consumers seeking specific apparel categories. Complementing this, the Wood Pellet Business segment sells wood pellets and sawdust, addressing energy or industrial material needs. These two segments represent the core physical product offerings of the company, targeting different consumer and industrial bases respectively. Additionally, the Other Business segment engages in online and offline education to foster human resources in the FinTech service, platform business, and block chain industry. This educational arm targets individuals and professionals seeking skills in emerging financial technologies. By combining physical goods with specialized training services, INBIOGEN CO., Ltd. diversifies its income streams across technology, retail, energy, and education sectors. InBioGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBioGen Co stock

R&D to Revenue Ratio of InBioGen Co is 0.31 % in 2024.

R&D to Revenue Ratio of InBioGen Co changed from 0.13 % to 0.31 %, representing a 136.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio InBioGen Co since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's InBioGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — InBioGen Co

All Key Metrics — InBioGen Co